INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2008

A 3.0 g/day dose of maca root significantly improved SSRI-induced sexual dysfunction scores, whereas a 1.5 g/day dose did not.

A double-blind pilot study evaluated low-dose (1.5 g/day) versus high-dose (3.0 g/day) maca in 20 remitted depressed outpatients with SSRI-induced sexual dysfunction. In intent-to-treat analyses, subjects on 3.0 g/day showed significant improvements in ASEX scores (from 22.8 +/- 3.8 to 16.9 +/- 6.2; P=0.028) and MGH-SFQ scores (from 24.1 +/- 1.9 to 17.0 +/- 5.7; P=0.017), while those on 1.5 g/day did not. Libido improved significantly based on ASEX item #1 for the ITT and completer groups (P<0.05), but not when analyzed by dosing groups. Maca was well tolerated.

Study type
Double-blind, randomized, parallel-group pilot dose-finding trial
Who was studied
20 remitted depressed outpatients (mean age 36 +/- 13 years; 17 women) with SSRI-induced sexual dysfunction
What was measured
Sexual dysfunction measured by ASEX and MGH-SFQ scores, and libido

THE PAPER

A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction.

Dording CM, Fisher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. CNS Neurosci Ther, 2008.

PubMed 18801111 ↗DOI 10.1111/j.1755-5949.2008.00052.x ↗

Brain & moodOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.